Literature DB >> 11455853

Spondylarthropathies: options for combination therapy.

A M van Tubergen1, R B Landewé, S van der Linden.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2001        PMID： 11455853     DOI： 10.1007/s002810100064

Source DB:  PubMed          Journal:  Springer Semin Immunopathol        ISSN： 0344-4325


× No keyword cloud information.
  69 in total

1.  Periarticular corticosteroid treatment of the sacroiliac joint in patients with seronegative spondylarthropathy.

Authors:  R Luukkainen; M Nissilä; E Asikainen; M Sanila; K Lehtinen; A Alanaatu; H Kautiainen
Journal:  Clin Exp Rheumatol       Date:  1999 Jan-Feb       Impact factor: 4.473

2.  An open study of pamidronate in the treatment of refractory ankylosing spondylitis.

Authors:  W P Maksymowych; G S Jhangri; S Leclercq; K Skeith; A Yan; A S Russell
Journal:  J Rheumatol       Date:  1998-04       Impact factor: 4.666

3.  Methotrexate treatment of psoriatic arthritis.

Authors:  H Zachariae; E Zachariae
Journal:  Acta Derm Venereol       Date:  1987       Impact factor: 4.437

4.  Comparison of sulfasalazine and placebo in the treatment of psoriatic arthritis. A Department of Veterans Affairs Cooperative Study.

Authors:  D O Clegg; D J Reda; E Mejias; G W Cannon; M H Weisman; T Taylor; E Budiman-Mak; W D Blackburn; F B Vasey; M L Mahowald; J J Cush; H R Schumacher; S L Silverman; F P Alepa; M E Luggen; M R Cohen; R Makkena; C M Haakenson; R H Ward; B J Manaster; R J Anderson; J R Ward; W G Henderson
Journal:  Arthritis Rheum       Date:  1996-12

5.  Short-term "cyclosporin A" therapy for psoriatic arthritis.

Authors:  V Riccieri; A Sili Scavalli; A Spadaro; M Bracci; E Taccari; A Zoppini
Journal:  Acta Derm Venereol Suppl (Stockh)       Date:  1994

6.  Intravenous methylprednisolone pulse therapy in severe ankylosing spondylitis.

Authors:  G Mintz; R D Enríquez; U Mercado; E J Robles; F J Jiménez; G Gutiérrez
Journal:  Arthritis Rheum       Date:  1981-05

7.  Treatment of psoriatic arthritis with oral 1,25-dihydroxyvitamin D3: a pilot study.

Authors:  D Huckins; D T Felson; M Holick
Journal:  Arthritis Rheum       Date:  1990-11

8.  Etanercept in the treatment of psoriatic arthritis and psoriasis: a randomised trial.

Authors:  P J Mease; B S Goffe; J Metz; A VanderStoep; B Finck; D J Burge
Journal:  Lancet       Date:  2000-07-29       Impact factor: 79.321

9.  Life-table analysis of cyclosporin A treatment in psoriatic arthritis: comparison with other disease-modifying antirheumatic drugs.

Authors:  A Spadaro; E Taccari; B Mohtadi; V Riccieri; F Sensi; A Zoppini
Journal:  Clin Exp Rheumatol       Date:  1997 Nov-Dec       Impact factor: 4.473

10.  A double-blind controlled trial of etretinate (Tigason) and ibuprofen in psoriatic arthritis.

Authors:  R Hopkins; H A Bird; H Jones; J Hill; K E Surrall; C Astbury; A Miller; V Wright
Journal:  Ann Rheum Dis       Date:  1985-03       Impact factor: 19.103
View more
  2 in total

Review 1.  Effects of physical therapy for the management of patients with ankylosing spondylitis in the biological era.

Authors:  Erika Giannotti; Sabina Trainito; Giovanni Arioli; Vincenzo Rucco; Stefano Masiero
Journal:  Clin Rheumatol       Date:  2014-05-07       Impact factor: 2.980

2.  Which patients with ankylosing spondylitis should be treated with tumour necrosis factor inhibiting therapy? A survey among Dutch rheumatologists.

Authors:  R Landewé; B Rump; D van der Heijde; S van der Linden
Journal:  Ann Rheum Dis       Date:  2004-05       Impact factor: 19.103
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.